The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
PHENYLEPHRINE ACCORD, PHENYLEPHRINE INTAS (Accord Healthcare Pty Ltd)
Product name
PHENYLEPHRINE ACCORD, PHENYLEPHRINE INTAS
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
157 working days (255)
Active ingredients
phenylephrine hydrochloride
Registration type
New generic medicine
Indication
PHENYLEPHRINE ACCORD, PHENYLEPHRINE INTAS (solution for injection) is intended for the maintenance of an adequate level of blood pressure during spinal and inhalation anaesthesia and for the treatment of vascular failure in shock, shock-like states, and drug-induced hypotension, or hypersensitivity. It is also employed to overcome paroxysmal supraventricular tachycardia, to prolong spinal anaesthesia, and as a vasoconstrictor in regional analgesia.